These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 34095319)

  • 1. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease.
    Chi M; Ma K; Wang J; Ding Z; Li Y; Zhu S; Liang X; Zhang Q; Song L; Liu C
    J Immunol Res; 2021; 2021():5516035. PubMed ID: 34095319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects.
    Mertowska P; Mertowski S; Wojnicka J; Korona-Głowniak I; Grywalska E; Błażewicz A; Załuska W
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-liver axis signaling in portal hypertension.
    Simbrunner B; Mandorfer M; Trauner M; Reiberger T
    World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
    Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
    Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.
    Konrad L; Andersen K; Kesper MS; Kumar SV; Mulay SR; Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):86-97. PubMed ID: 31081025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice.
    Watanabe IKM; Andrade-Silva M; Foresto-Neto O; Felizardo RJF; Matheus MAC; Silva RC; Cenedeze MA; Honda TSB; Perandini LAB; Volpini RA; Pacheco-Silva A; Câmara NOS
    Front Immunol; 2020; 11():578623. PubMed ID: 33414781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide.
    Zhang J; Yang G; Wen Y; Liu S; Li C; Yang R; Li W
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28679026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consequences of altered microbiota in immune-related chronic kidney disease.
    Lau WL; Chang Y; Vaziri ND
    Nephrol Dial Transplant; 2021 Sep; 36(10):1791-1798. PubMed ID: 32437554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.